Scientists have developed a computer-based model that may explain how nerve cells become damaged in ALS, and how best to time ...

Mindwalk identified TDP-43 antibodies that selectively target abnormal protein clumps linked to ALS and other diseases.

Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease with no cure and limited treatment options. One of the earliest signs of ALS is overactive brain signals known as ...

University of Utah researchers at the Pulst-Scoles Laboratory have discovered that reducing levels of the STAUFEN-1 protein ...

The FDA has granted fast track designation to a vectorized antibody that targets RNA-binding proteins characteristic of ...

A look at Amyotrophic Lateral Sclerosis (ALS), focusing on motor neuron degeneration, sporadic versus familial ...

LONDON, ONTARIO (CTV Network) — New research out of London, Ont.’s Western University is shedding light on a potential cure for ALS, in which the targeting of the interaction between two proteins can ...

It's a terminal disease, currently with no cure. ALS impacts tens of thousands of people across the United States, and hundreds in Arizona. There's research being done in the Valley that can hopefully ...

DURHAM -- August is the month the Ice Bucket Challenge kicks off, and Tuesday the Duke ALS Clinic joined in with an Ice Bucket Challenge of its own. The director of the clinic and leading ALS ...

An error has occurred. Please try again. With a The Portland Press Herald subscription, you can gift 5 articles each month. It looks like you do not have any active ...

Erik P Pioro consults for MT Pharma, which manufactures edaravone (Radicava) and for Biogen, which manufactures tofersen (Qalsody). He has received funding support for ALS research from the ALS ...